Seoul Biohub resident company Backsdime (CEO Kim Seong-jae) announced on the 3rd that it was selected for the '2025 Patent R&D Strategy Support Project' hosted by the Korean Intellectual Property Office and the Korea Patent Strategy Development Institute.
Baxdime is a vaccine specialist company that possesses the original technology for rapid production of microbial-based protein antigens. Through this project, it plans to begin in earnest securing intellectual property rights (IP) for the development of a Japanese encephalitis vaccine based on genetically recombinant synthetic antigens. The main development scope includes the establishment of cell lines for production, optimization of the culture and purification process, and development of formulation compositions.
This project will be carried out for approximately 20 weeks in conjunction with the Japanese encephalitis vaccine development project (total of 1 billion won, including corporate contribution) within the ‘2024 Essential Vaccination Self-Sufficiency’ field promoted by the Vaccine Commercialization Technology Development Center (VITAL-Korea) under the Ministry of Health and Welfare.
With this support, Backsdime plans to establish a patent-based technology strategy in three stages: ▲establishing a strategy for avoiding and responding to rights through prior patent analysis (Stage 1), ▲proposing an R&D strategy for process improvement and entry into new markets (Stage 2), and ▲establishing a strategy for creating new patents to protect technology and preempt unentered fields (Stage 3).
CEO Kim Sung-jae said, “Through Seoul Biohub’s networking program, we have come to realize the importance of establishing an IP strategy,” and “We plan to focus on securing intellectual property rights for core technologies related to Japanese encephalitis vaccines based on our own original technology, the ‘Chaperna’ platform.” He added, “We expect that this strategy will go beyond technology protection and contribute to entering the next-generation vaccine market and establishing a foundation for global expansion.”
- See more related articles
You must be logged in to post a comment.